In mice, Atf4-targeted deletion has been shown to result in C-cell hyperplasia (CCH), Atf4 over-expression, and decreased MTC cell survival, and it inhibited the activation of the RET downstream pathway [97]. Here, ATF4 is linked to medullary thyroid gland carcinoma.